FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Philippe Moreau

Research Profile

Chemicals & Drugs

Disorders

Multiple Myeloma

Procedures

Concepts & Ideas

Physiology

Pregnancy

Anatomy

Tumor Cell Line

Co-author Network

Publications

TOP 3
A Clavert; J Delaunay; V Dubruille; Thomas Gastinne; T Guillaume; Steven Le Gouill; Béatrice Mahe; N Blin; Patrice Chevallier; Philippe Moreau; Mohamad Mohty
Safety and efficacy of rituximab in steroid-refractory chronic GVHD.
S Maïga; Philippe Moreau; Catherine Pellat-Deceunynck; Stéphanie Bonnaud; Patricia Gomez-Bougie; C Gratas; Steven Le Gouill; Martine Amiot
Paradoxical effect of lenalidomide on cytokine/growth factor profiles in multiple myeloma.
Xavier Leleu; Margaret Macro; Gerald Marit; Claire Mathiot; Nathalie Meuleman; Mauricette Michallet; Philippe Moreau; Brigitte Pegourie; Marie Odile Petillon; Murielle Roussel; Bruno Royer; Anne Marie Stoppa; Beatrice Thielemans; Catherine Traulle; Bertrand Arnulf; Michel Attal; Hervé Avet-Loiseau; Lotfi Benboubker; Sabine Bréchignac; Denis Caillot; Olivier Decaux; Martine Escoffre-Barbe; Thierry Facon; Jean-Paul Fermand; Laurent Garderet; Bernadette Hennache; Cyrille Hulin; Brigitte Kolb
Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myélome 2009-02.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Philippe Moreau (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: A Clavert; J Delaunay; V Dubruille; Thomas Gastinne; T Guillaume; Steven Le Gouill; Béatrice Mahe; N Blin; Patrice Chevallier; Philippe Moreau; Mohamad Mohty
Safety and efficacy of rituximab in steroid-refractory chronic GVHD.
Bone marrow transplantation 2013;48(5):734-6.
2013: S Maïga; Philippe Moreau; Catherine Pellat-Deceunynck; Stéphanie Bonnaud; Patricia Gomez-Bougie; C Gratas; Steven Le Gouill; Martine Amiot
Paradoxical effect of lenalidomide on cytokine/growth factor profiles in multiple myeloma.
British journal of cancer 2013;108(9):1801-6.
2013: Xavier Leleu; Margaret Macro; Gerald Marit; Claire Mathiot; Nathalie Meuleman; Mauricette Michallet; Philippe Moreau; Brigitte Pegourie; Marie Odile Petillon; Murielle Roussel; Bruno Royer; Anne Marie Stoppa; Beatrice Thielemans; Catherine Traulle; Bertrand Arnulf; Michel Attal; Hervé Avet-Loiseau; Lotfi Benboubker; Sabine Bréchignac; Denis Caillot; Olivier Decaux; Martine Escoffre-Barbe; Thierry Facon; Jean-Paul Fermand; Laurent Garderet; Bernadette Hennache; Cyrille Hulin; Brigitte Kolb
Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myélome 2009-02.
Blood 2013;121(11):1968-75.
2013: Amandine Le Bourgeois; Steven Le Gouill; Elsa Lestang; Béatrice Mahe; Mohamad Mohty; Philippe Moreau; Lucie Planche; Virginie Roland; Benoit Tessoulin; Aline Clavert; Jacques Delaunay; Viviane Dubruille; Thomas Gastinne; Thierry Guillaume; Sameh Ayari; Nicolas Blin; Patrice Chevallier
Prognostic impact of immune status and hematopoietic recovery before and after fludarabine, IV busulfan, and antithymocyte globulins (FB2 regimen) reduced-intensity conditioning regimen (RIC) allogeneic stem cell transplantation (allo-SCT).
European journal of haematology 2013;90(3):177-86.
2013: Emilie Lemieux; Marion Loirat; Jessica Michel; Denis Caillot; Véronique Dorvaux; Thomas Gastinne; Cyrille Hulin; Ingrid Lafon; Caroline Legouge; Lucie Planche; Cédric Rossi; Stéphanie Tardy; Cyrille Touzeau; Philippe Moreau
Autologous stem cell transplantation: an effective salvage therapy in multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(3):445-9.
2013: Hervé Avet-Loiseau; B Barlogie; M Cavo; J Crowley; B G M Durie; R Fonseca; H Goldschmidt; N Gutierrez; J Haessler; R Hajek; J Lahuerta; J H Lee; Philippe Moreau; G Morgan; S V Rajkumar; F Ross; O Sezer; P Sonneveld; N Testoni; Michel Attal
Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project.
Leukemia 2013;27(3):711-7.
2013: Isabela J Wastowski; Layale Yaghi; João T Pancoto; Isabelle Poras; Renata T Simões; Samuel Valable; Myriam Bernaudin; Carlos G Carlotti; Edgardo D Carosella; Eduardo A Donadi; Soldano Ferrone; Sébastien Flajollet; Stine S Jensen; Bjarne W Kristensen; Emmanuèle Lechapt-Zalcman; Philippe Moreau
Human leukocyte antigen-G is frequently expressed in glioblastoma and may be induced in vitro by combined 5-aza-2'-deoxycytidine and interferon-γ treatments: results from a multicentric study.
The American journal of pathology 2013;182(2):540-52.
2013: Florence Magrangeas; Gérald Marit; Philippe Moreau; Nikhil C Munshi; E Randriamalala; Anne-Marie Stoppa; M Tiab; Laurent Voillat; E Voog; Kenneth C Anderson; Hervé Avet-Loiseau; Philippe Casassus; Olivier Decaux; Thierry Facon; Laurent Garderet; P Godmer; W Gouraud; Cyrille Hulin; Laurence Lodé; Stéphane Minvielle
Minor clone provides a reservoir for relapse in multiple myeloma.
Leukemia 2013;27(2):473-81.
2012: Olivier Decaux; Thierry Facon; Bernard Grosbois; Philippe Moreau; Brigitte Pegourie; Alain Renault; Véronique Sébille; Mourad Tiab; Laurent Voillat; Robert Zerbib; Michel Attal; Eric Bellissant
Predictive factors of survival after thalidomide therapy in advanced multiple myeloma: long-term follow-up of a prospective multicenter nonrandomized phase II study in 120 patients.
Clinical lymphoma, myeloma & leukemia 2012;12(6):418-22.
2012: Philippe Moreau; Alexander Schmidt; Donna M Skee; Helgi van de Velde; Karthik Venkatakrishnan; Kateryna V Vilchevska; Andrew Cakana; William Deraedt; Natalia Domnikova; Vadim A Doronin; Dixie Esseltine; Huaibao Feng; Suzette Girgis; Cyrille Hulin; Ievgenii I Karamanesht; Maryna Y Kyselyova; Xavier Leleu; Thierry Facon
Pharmacokinetic, pharmacodynamic and covariate analysis of subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma.
Clinical pharmacokinetics 2012;51(12):823-9.
2012: Antoine Néel; Sébastien Barbarot; Olivier Espitia; Muriel Hello; Frédérique Jossic; Agathe Masseau; Philippe Moreau; Lucile Musset; Jean-Marie Mussini; Mohamed Hamidou
Skin patch, polyneuropathy, and paraproteinemia.
The American journal of medicine 2012;125(12):e1-2.
2012: Bertrand Arnulf; Andrew Cakana; William Deraedt; Huaibao Feng; Sebastian Grosicki; Ievgenii Karamanesht; Xavier Leleu; Halyna Pylypenko; Helgi van de Velde; Philippe Moreau
Updated survival analysis of a randomized phase III study of subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma.
Haematologica 2012;97(12):1925-8.
2012: Philippe Moreau; Sergio A Giralt
Optimizing therapy for transplant-eligible patients with newly diagnosed multiple myeloma.
Leukemia research 2012;36 Suppl 1():S13-8.
2012: Steven Le Gouill; C Leux; Noël Milpied; U Bacher; K Bouabdallah; Claude-Eric Bulabois; Agnès Buzyn; Nathalie Dhedin; Jean-Luc Harousseau; T Kanouni; N Kröger; M P Moles; Philippe Moreau; Arnon Nagler; S Ocheni; Bernard Rio; A Shimoni; Olivier Tournilhac; Ibrahim Yakoub-Agha; Mohamad Mohty
Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(10):2695-703.
2012: Sylvanie Surget; Martine Amiot; Régis Bataille; David CHIRON; Géraldine Descamps; Patricia Gomez-Bougie; Steven Le Gouill; Emmanuelle Ménoret; Philippe Moreau; Catherine Pellat-Deceunynck
Cell death via DR5, but not DR4, is regulated by p53 in myeloma cells.
Cancer research 2012;72(17):4562-73.
2012: Pierre Peterlin; Virginie Roland; Soraya Wuilleme; Christophe Leux; Béatrice Mahé; Noel Milpied; Mohamad Mohty; Anne Moreau; Philippe Moreau; Sameh Ayari; Nicolas Blin; Patrice Chevallier; Aline Clavert; Jacques Delaunay; Christelle Dousset; Viviane Dubruille; Thomas Gastinne; Thierry Guillaume; Jean-Luc Harousseau; Steven Le Gouill
Is ASCT with TBI superior to ASCT without TBI in mantle cell lymphoma patients?
Transplantation 2012;94(3):295-301.
2012: Philippe Moreau; Robert Z Orlowski; Antonio Palumbo; Paul G Richardson; Jesús F San Miguel; Michele Cavo; Jean-Luc Harousseau
Proteasome inhibitors in multiple myeloma: 10 years later.
Blood 2012;120(5):947-59.
2012: Laurent Garderet; Norbert-Claude Gorin; Alois Gratwohl; Roman Hajek; Jean-Luc Harousseau; Bernd Hertenstein; Simona Iacobelli; Nicolas Ketterer; Christian Koenecke; Brigitte Kolb; Ingrid Lafon; Heinz Ludwig; Tamas Masszi; Mauricette Michallet; Giuseppe Milone; Mohamad Mohty; Philippe Moreau; Curly Morris; Dietger Niederwieser; Francesco Onida; Brigitte Pegourie; Marleen van Os; Andrew Cakana; Philippe Casassus; Carine Chaleteix; Theo de Witte; Michel DIB; Chantal Doyen; Jean Fontan; Gösta Gahrton
Superiority of the triple combination of bortezomib-thalidomide-dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: the MMVAR/IFM 2005-04 Randomized Phase III Trial from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(20):2475-82.
2012: Philippe Moreau
The future of therapy for relapsed/refractory multiple myeloma: emerging agents and novel treatment strategies.
Seminars in hematology 2012;49 Suppl 1():S33-46.
2012: Cyrille Touzeau; Patrice Chevallier; Anne Devys; Gilles Folléa; Katia Gagne; Patricia Herry; Mohamad Mohty; Philippe Moreau; Véronique Sébille; Anne Cesbron Gautier
Investigation of the impact of HLA-DPB1 matching status in 10/10 HLA matched unrelated hematopoietic stem cell transplantation: results of a French single center study.
Human immunology 2012;73(7):711-4.
2012: Cyrille Touzeau; Steven Le Gouill; Martine Pennetier; Pierre Peterlin; Lucie Planche; Virginie Roland; Benoit Tessoulin; Nicolas Blin; Aline Clavert; Viviane Dubruille; Marion Loirat; Beatrice Mahe; Florent Malard; Mohamad Mohty; Philippe Moreau
Efficacy of lenalidomide plus dexamethasone in patients older than 75 years with relapsed multiple myeloma.
Leukemia & lymphoma 2012;53(7):1318-20.
2012: Hervé Avet-Loiseau; Anne Banos; Didier Bouscary; Denis Caillot; Loïc Campion; Thierry Facon; Cyrille Hulin; Jerome Jaubert; Brigitte Kolb; Margaret Macro; Florence Magrangeas; Gérald Marit; Claire Mathiot; Stéphane Minvielle; Brigitte Pegourie; Anne-Marie Stoppa; Mourad Tiab; Catherine Traulle; Laurent Voillat; Eric Voog; Marc Wetterwald; Michel Attal; Philippe Moreau
Long-term analysis of the IFM 99 trials for myeloma: cytogenetic abnormalities [t(4;14), del(17p), 1q gains] play a major role in defining long-term survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(16):1949-52.
2012: Philippe Moreau; S Vincent Rajkumar
"Should all eligible patients with multiple myeloma receive autologous stem-cell transplant as part of initial treatment?".
Leukemia research 2012;36(6):677-81.
2012: Michel Attal; Hervé Avet-Loiseau; Lotfi Benboubker; Denis Caillot; Olivier Decaux; Charles Dumontet; Thierry Facon; Laurent Garderet; Jean-Luc Harousseau; Cyrille Hulin; Valerie Lauwers-Cances; Xavier Leleu; Serge Leyvraz; Gerald Marit; Claire Mathiot; Mauricette Michallet; Philippe Moreau; Catherine Payen; Brigitte Pegourie; Murielle Roussel; Anne Marie Stoppa; Marie-Christiane Vekemans; Laurent Voillat
Lenalidomide maintenance after stem-cell transplantation for multiple myeloma.
The New England journal of medicine 2012;366(19):1782-91.
2012: Géraldine Descamps; Patricia Gomez-Bougie; A Green; Steven Le Gouill; S Maïga; Philippe Moreau; Catherine Pellat-Deceunynck; J Tamburini; D Bouscary; Martine Amiot
The cap-translation inhibitor 4EGI-1 induces apoptosis in multiple myeloma through Noxa induction.
British journal of cancer 2012;106(10):1660-7.
2012: David CHIRON; Géraldine Descamps; Bernard Klein; Steven Le Gouill; Sophie Maïga; Séverine Marionneau; Philippe Moreau; Jérôme Moreaux; Thibauld Ouiller; Martine Amiot; Régis Bataille; Catherine Pellat-Deceunynck
Critical role of the NOTCH ligand JAG2 in self-renewal of myeloma cells.
Blood cells, molecules & diseases 2012;48(4):247-53.
2012: M Cuisinier; T Epicier; D Guyomard; R Kanno; J F Martin; Philippe Moreau; N Dupré
Quantitative MAS NMR characterization of the LiMn(1/2)Ni(1/2)O(2) electrode/electrolyte interphase.
Solid state nuclear magnetic resonance 2012;42():51-61.
2012: Jill Corre; Nicolas Espagnolle; Thierry Facon; Jean-Jacques Fournié; Mélanie Gadelorge; Benjamin Hébraud; A Huynh; Bernard Klein; Elodie Labat; Philippe Moreau; Murielle Roussel; Michel Attal; Hervé Avet-Loiseau; Pierre Cordelier; philippe Bourin
Bioactivity and prognostic significance of growth differentiation factor GDF15 secreted by bone marrow mesenchymal stem cells in multiple myeloma.
Cancer research 2012;72(6):1395-406.
2012: Ibrahim Yakoub-Agha; Robert Zerbib; Lotfi Benboubker; Christian Berthou; Philippe Casassus; Ghandi Damaj; Mamoun Dib; Chantal Doyen; Thierry Facon; Jean-Luc Harousseau; Cyrille Hulin; Frédéric Maloisel; Gérald Marit; Jean-Yves Mary; Mohamad Mohty; Philippe Moreau; Brigitte Pegourie; Philippe Rodon; Borhane Slama; Anne-Marie Stoppa; Laurent Voillat
Low-dose vs. high-dose thalidomide for advanced multiple myeloma: a prospective trial from the Intergroupe Francophone du Myélome.
European journal of haematology 2012;88(3):249-59.
2012: Z Peric; B Saulquin; Philippe Moreau; S Ayari; N Blin; E Brissot; X Cahu; Patrice Chevallier; Marianne Coste-Burel; J Delaunay; V Dubruille; Thomas Gastinne; T Guillaume; Jean-Luc Harousseau; Berthe-Marie Imbert-Marcille; Steven Le Gouill; Béatrice Mahé; F Malard; Mohamad Mohty
Features of EBV reactivation after reduced intensity conditioning unrelated umbilical cord blood transplantation.
Bone marrow transplantation 2012;47(2):251-7.
2011: Florent Malard; Noel Miplied; Philippe Moreau; Sameh Ayari; Nicolas Blin; Eolia Brissot; Xavier Cahu; Patrice Chevallier; Aline Clavert; Jacques Delaunay; Viviane Dubruille; Thomas Gastinne; Thierry Guillaume; Jean-Luc Harousseau; Steven Le Gouill; Béatrice Mahe; Mohamad Mohty
Fludarabine, antithymocyte globulin, and very low-dose busulfan for reduced-intensity conditioning before allogeneic stem cell transplantation in patients with lymphoid malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(11):1698-703.
2011: Linda Bodet; Géraldine Descamps; Christelle Dousset; Patricia Gomez-Bougie; Steven Le Gouill; Sophie Maïga; Philippe Moreau; Catherine Pellat-Deceunynck; Cyrille Touzeau; Hervé Avet-Loiseau; Régis Bataille; Martine Amiot
ABT-737 is highly effective against molecular subgroups of multiple myeloma.
Blood 2011;118(14):3901-10.
2011: Cyrille Touzeau; Anne Moreau; Philippe Moreau; Catherine Pellat-Deceunynk; Martine Amiot; Linda Bodet; Stéphanie Bonnaud; Christelle Dousset; Patricia Gomez-Bougie; Steven Le Gouill
ABT-737 induces apoptosis in mantle cell lymphoma cells with a Bcl-2high/Mcl-1low profile and synergizes with other antineoplastic agents.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(18):5973-81.
2011: Peter M Fayers; Peter Gimsing; Rauf Haznedar; Cyrille Hulin; Jean-Yves Mary; Philippe Moreau; Pellegrino Musto; Antonio Palumbo; Martijn Schaafsma; Pieter Sonneveld; Fabian Termorshuizen; Ingemar Turesson; Anders Waage; Pierre Wijermans; Meral Beksaç; Lotfi Benboubker; Sara Bringhen; Tommaso Caravita; Thierry Facon
Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials.
Blood 2011;118(5):1239-47.
2011: Steven Le Gouill; Mohamad Mohty; Thomas Gastinne; Thierry Guillaume; Philippe Moreau
Allogeneic stem cell transplantation in mantle cell lymphoma: where are we now and which way should we go?
Seminars in hematology 2011;48(3):227-39.
2011: Philippe Moreau; M Attal; Jean-Luc Harousseau
New developments in conditioning regimens before auto-SCT in multiple myeloma.
Bone marrow transplantation 2011;46(7):911-5.
2011: Z Peric; B Saulquin; Philippe Moreau; S Ayari; N Blin; E Brissot; X Cahu; Patrice Chevallier; Marianne Coste-Burel; J Delaunay; V Dubruille; Thomas Gastinne; T Guillaume; Jean-Luc Harousseau; Berthe-Marie Imbert-Marcille; Steven Le Gouill; Béatrice Mahe; F Malard; Noël Milpied; Mohamad Mohty
Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation.
Leukemia 2011;25(6):932-8.
2011: Philippe Moreau; Halyna Pylypenko; Sebastian Grosicki; Ievgenii Karamanesht; Xavier Leleu; Maria Grishunina; Grigoriy Rekhtman; Zvenyslava Masliak; Tadeusz Robak; Anna Shubina; Bertrand Arnulf; Martin Kropff; James Cavet; Dixie Esseltine; Huaibao Feng; Suzette Girgis; Helgi van de Velde; William Deraedt; Jean-Luc Harousseau
Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study.
The lancet oncology 2011;12(5):431-40.
2011: Philippe Moreau; F Cavallo; Xavier Leleu; Cyrille Hulin; Martine Amiot; G Descamps; Thierry Facon; Mario Boccadoro; D Mignard; Jean-Luc Harousseau
Phase I study of the anti insulin-like growth factor 1 receptor (IGF-1R) monoclonal antibody, AVE1642, as single agent and in combination with bortezomib in patients with relapsed multiple myeloma.
Leukemia 2011;25(5):872-4.
2011: Philippe Moreau; Michel Attal; Brigitte Pégourié; Lucie Planche; Cyrille Hulin; Thierry Facon; Anne-Marie Stoppa; Jean-Gabriel Fuzibet; Bernard Grosbois; Chantal Doyen; Nicolas Ketterer; Catherine Sebban; Brigitte Kolb; Carine Chaleteix; Mamoun Dib; Laurent Voillat; Jean Fontan; Laurent Garderet; Jérôme Jaubert; Claire Mathiot; Dixie Esseltine; Hervé Avet-Loiseau; Jean-Luc Harousseau
Achievement of VGPR to induction therapy is an important prognostic factor for longer PFS in the IFM 2005-01 trial.
Blood 2011;117(11):3041-4.
2011: X Cahu; C Bodet-Milin; E Brissot; H Maisonneuve; R Houot; N Morineau; P Solal-Celigny; P Godmer; Thomas Gastinne; Philippe Moreau; A Moreau; Thierry Lamy; F Kraber-Bodere; Steven Le Gouill
18F-fluorodeoxyglucose-positron emission tomography before, during and after treatment in mature T/NK lymphomas: a study from the GOELAMS group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(3):705-11.
2011: V Roland; Caroline Bodet-Milin; Anne Moreau; Thomas Gastinne; Béatrice Mahé; V Dubruille; Hervé Maisonneuve; Nadine Juge-Morineau; Philippe Moreau; Henri Jardel; L Planche; Mohamad Mohty; P Moreau; Jean-Luc Harousseau; Françoise Kraeber-Bodéré; Steven Le Gouill
Impact of high-dose chemotherapy followed by auto-SCT for positive interim [18F] FDG-PET diffuse large B-cell lymphoma patients.
Bone marrow transplantation 2011;46(3):393-9.
2010: L Bodet; E Ménoret; Géraldine Descamps; Catherine Pellat-Deceunynck; Régis Bataille; Steven Le Gouill; Philippe Moreau; Martine Amiot; Patricia Gomez-Bougie
BH3-only protein Bik is involved in both apoptosis induction and sensitivity to oxidative stress in multiple myeloma.
British journal of cancer 2010;103(12):1808-14.
2010: Philippe Moreau; Arnaud Jaccard; Lotfi Benboubker; Bruno Royer; Xavier Leleu; Franck Bridoux; Gilles Salles; Veronique Leblond; Murielle Roussel; May Alakl; Olivier Hermine; Lucie Planche; Jean-Luc Harousseau; Jean-Paul Fermand
Lenalidomide in combination with melphalan and dexamethasone in patients with newly diagnosed AL amyloidosis: a multicenter phase 1/2 dose-escalation study.
Blood 2010;116(23):4777-82.
2010: Michel Bourguignon; Layale Yaghi; Sébastien Flajollet; Irène Radanne-Krawice; Nathalie Rouas-Freiss; Didier Lugrin; Jean-Paul Richalet; Edgardo D Carosella; Philippe Moreau
Increased soluble human leukocyte antigen-G levels in peripheral blood from climbers on Mount Everest.
Human immunology 2010;71(11):1105-8.
2010: Laurence Lodé; Marion Eveillard; Valérie Trichet; Thierry Soussi; Soraya Wuillème; Steven Richebourg; Florence Magrangeas; Norbert Ifrah; Loïc Campion; Catherine Traullé; François Guilhot; Denis Caillot; Gérald Marit; Claire Mathiot; Thierry Facon; Michel Attal; Jean-Luc Harousseau; Philippe Moreau; Stéphane Minvielle; Hervé Avet-Loiseau
Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma.
Haematologica 2010;95(11):1973-6.
2010: Hervé Avet-Loiseau; Xavier Leleu; Murielle Roussel; Philippe Moreau; Catherine Guerin-Charbonnel; Denis Caillot; Gérald Marit; Lotfi Benboubker; Laurent Voillat; Claire Mathiot; Brigitte Kolb; Margaret Macro; Loïc Campion; Marc Wetterwald; Anne-Marie Stoppa; Cyrille Hulin; Thierry Facon; Michel Attal; Stéphane Minvielle; Jean-Luc Harousseau
Bortezomib plus dexamethasone induction improves outcome of patients with t(4;14) myeloma but not outcome of patients with del(17p).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(30):4630-4.
2010: Aline Clavert; Steven Le Gouill; Eolia Brissot; Viviane Dubruille; Beatrice Mahe; Thomas Gastinne; Nicolas Blin; Patrice Chevallier; Thierry Guillaume; Jacques Delaunay; Sameh Ayari; Beatrice Saulquin; Anne Moreau; Philippe Moreau; Jean-Luc Harousseau; Noël Milpied; Mohamad Mohty
Reduced-intensity conditioning allogeneic stem cell transplant for relapsed or transformed aggressive B-cell non-Hodgkin lymphoma.
Leukemia & lymphoma 2010;51(8):1502-8.
2010: Caroline Bodet-Milin; Cyrille Touzeau; Christophe Leux; Mehmet Sahin; Anne Moreau; Hervé Maisonneuve; Nadine Morineau; Henri Jardel; Philippe Moreau; Céline Gallazini-Crépin; Pascal Gries; Rémy Gressin; Jean-Luc Harousseau; Mohamad Mohty; Philippe Moreau; Françoise Kraeber-Bodere; Steven Le Gouill
Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS group.
European journal of nuclear medicine and molecular imaging 2010;37(9):1633-42.
2010: Philippe Moreau; Cyrille Hulin; Gérald Marit; Denis Caillot; Thierry Facon; P Lenain; Christian Berthou; B Pégourié; Anne-Marie Stoppa; Philippe Casassus; Mauricette Michallet; Lotfi Benboubker; H Maisonneuve; Chantal Doyen; S Leyvraz; Claire Mathiot; Hervé Avet-Loiseau; Michel Attal; Jean-Luc Harousseau
Stem cell collection in patients with de novo multiple myeloma treated with the combination of bortezomib and dexamethasone before autologous stem cell transplantation according to IFM 2005-01 trial.
Leukemia 2010;24(6):1233-5.
2010: E Brissot; Patrice Chevallier; T Guillaume; J Delaunay; S Ayari; V Dubruille; Steven Le Gouill; B Mahe; Thomas Gastinne; N Blin; B Saulquin; Philippe Moreau; Jean-Luc Harousseau; Mohamad Mohty
Prophylaxis with mycophenolate mofetil and CsA can decrease the incidence of severe acute GVHD after antithymocyte globulin-based reduced-intensity preparative regimen and allo-SCT from HLA-matched unrelated donors.
Bone marrow transplantation 2010;45(4):786-8.
2010: Inès Zidi; Chrsitine Guillard; Edgardo D Carosella; Philippe Moreau
Soluble HLA-G induces NF-kappaB activation in natural killer cells.
Journal of physiology and biochemistry 2010;66(1):39-46.
2010: Julien Danet; Thierry Brousse; Karsten Rasim; Dominique Guyomard; Philippe Moreau
Valence electron energy-loss spectroscopy of silicon negative electrodes for lithium batteries.
Physical chemistry chemical physics : PCCP 2010;12(1):220-6.
2010: Murielle Roussel; Philippe Moreau; A Huynh; Jean-Yves Mary; Clotaire Danho; Denis Caillot; Cyrille Hulin; Christophe Fruchart; Gérald Marit; Brigitte Pégourié; Pascal Lenain; Carla Araujo; Brigitte Kolb; Edouard Randriamalala; Bruno Royer; Anne-Marie Stoppa; Mamoun Dib; Véronique Dorvaux; Laurent Garderet; Claire Mathiot; Hervé Avet-Loiseau; Jean-Luc Harousseau; Michel Attal
Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase 2 study of the Intergroupe Francophone du Myelome (IFM).
Blood 2010;115(1):32-7.
2010: Florent Malard; Richard M Szydlo; Eolia Brissot; Patrice Chevallier; Thierry Guillaume; Jacques Delaunay; Sameh Ayari; Viviane Dubruille; Steven Le Gouill; Beatrice Mahe; Thomas Gastinne; Nicolas Blin; Beatrice Saulquin; Jean-Luc Harousseau; Philippe Moreau; Mohamad Mohty
Impact of cyclosporine-A concentration on the incidence of severe acute graft-versus-host disease after allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(1):28-34.
2009: Xavier Cahu; Fanny Rialland; Cyrille Touzeau; Patrice Chevallier; Thierry Guillaume; Jacques Delaunay; Sameh Ayari; Viviane Dubruille; Steven Le Gouill; Beatrice Mahe; Thomas Gastinne; Nicolas Blin; Beatrice Saulquin; Jean-Luc Harousseau; Philippe Moreau; Mohamad Mohty
Infectious complications after unrelated umbilical cord blood transplantation in adult patients with hematologic malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(12):1531-7.
2009: Sébastien Flajollet; Isabelle Poras; Edgardo D Carosella; Philippe Moreau
RREB-1 is a transcriptional repressor of HLA-G.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(11):6948-59.
2009: E Brissot; P Chevallier; T Guillaume; J Delaunay; S Ayari; V Dubruille; Steven Le Gouill; B Mahe; Thomas Gastinne; N Blin; B Saulquin; G Flandrois; A Devys; V Stocco; A Cesbron; F Dehaut; Philippe Moreau; Jean-Luc Harousseau; Mohamad Mohty
Factors predicting allogeneic PBSCs yield after G-CSF treatment in healthy donors.
Bone marrow transplantation 2009;44(9):613-5.
2009: Hervé Avet-Loiseau; Cheng Li; Florence Magrangeas; Wilfried Gouraud; Catherine Charbonnel; Jean-Luc Harousseau; Michel Attal; Gerald Marit; Claire Mathiot; Thierry Facon; Philippe Moreau; Kenneth C Anderson; Loïc Campion; Nikhil C Munshi; Stéphane Minvielle
Prognostic significance of copy-number alterations in multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(27):4585-90.
2009: Philippe Moreau; Sébastien Flajollet; Edgardo D Carosella
Non-classical transcriptional regulation of HLA-G: an update.
Journal of cellular and molecular medicine 2009;13(9B):2973-89.
2009: Cyrille Hulin; Thierry Facon; Philippe Rodon; Brigitte Pegourie; Lotfi Benboubker; Chantal Doyen; Michel DIB; Gaelle Guillerm; Bruno Salles; Jean-Paul Eschard; Pascal Lenain; Philippe Casassus; Isabelle Azaïs; Olivier Decaux; Laurent Garderet; Claire Mathiot; Jean Fontan; Ingrid Lafon; jean-marc virion; Philippe Moreau
Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(22):3664-70.
2009: Philippe Moreau
Communications on multiple myeloma.
Expert review of hematology 2009;2(2):129-31.
2009: Géraldine Descamps; P Gomez-Bougie; Corinne Venot; Philippe Moreau; Régis Bataille; Martine Amiot
A humanised anti-IGF-1R monoclonal antibody (AVE1642) enhances Bortezomib-induced apoptosis in myeloma cells lacking CD45.
British journal of cancer 2009;100(2):366-9.
2008: Philippe Moreau; Valerie Coiteux; Cyrille Hulin; Xavier Leleu; Helgi van de Velde; Milin Acharya; Jean-Luc Harousseau
Prospective comparison of subcutaneous versus intravenous administration of bortezomib in patients with multiple myeloma.
Haematologica 2008;93(12):1908-11.
2008: Emmanuelle Ménoret; Sophie Maïga; Géraldine Descamps; Catherine Pellat-Deceunynck; Caroline Fraslon; Melania Cappellano; Philippe Moreau; Régis Bataille; Martine Amiot
IL-21 stimulates human myeloma cell growth through an autocrine IGF-1 loop.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(10):6837-42.
2008: Philippe Moreau; Cyrille Hulin; Thierry Facon
Frontline treatment of multiple myeloma in elderly patients.
Blood reviews 2008;22(6):303-9.
2008: Philippe Moreau; Licinio Contu; Francesco Alba; Sara Lai; Renata Simoes; Sandro Orrù; Carlo Carcassi; Michel Roger; Michèle Rabreau; Edgardo D Carosella
HLA-G gene polymorphism in human placentas: possible association of G*0106 allele with preeclampsia and miscarriage.
Biology of reproduction 2008;79(3):459-67.
2008: Edgardo D Carosella; Philippe Moreau; Joël LeMaoult; Nathalie Rouas-Freiss
HLA-G: from biology to clinical benefits.
Trends in immunology 2008;29(3):125-32.
2008: Chrsitine Guillard; Inès Zidi; Céline Marcou; Catherine Menier; Edgardo D Carosella; Philippe Moreau
Role of HLA-G in innate immunity through direct activation of NF-kappaB in natural killer cells.
Molecular immunology 2008;45(2):419-27.
2007: Nathalie Rouas-Freiss; Philippe Moreau; Catherine Menier; Joël LeMaoult; Edgardo D Carosella
Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses.
Seminars in cancer biology 2007;17(6):413-21.
2007: Steven Le Gouill; Pascaline Talmant; Cyrille Touzeau; Anne Moreau; Richard Garand; Nadine Juge-Morineau; Fanny Gaillard; Thomas Gastinne; Noël Milpied; Philippe Moreau; Jean-Luc Harousseau; Hervé Avet-Loiseau
The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement.
Haematologica 2007;92(10):1335-42.
2007: Déborah Sangrouber; Céline Marcou; Magali Le Discorde; Chien-Chung Chang; Edgardo D Carosella; Philippe Moreau
Cellular co-localization of intron-4 containing mRNA and HLA-G soluble protein in melanoma analyzed by fluorescence in situ hybridization.
Journal of immunological methods 2007;326(1-2):54-62.
2007: Arnaud Jaccard; Philippe Moreau; Véronique Leblond; Xavier Leleu; Lotfi Benboubker; Olivier Hermine; Christian Recher; Bouchra Asli; Bruno Lioure; Bruno Royer; Fabrice Jardin; Frank Bridoux; Bernard Grosbois; Jérôme Jaubert; Jean-Charles Piette; Pierre Ronco; Fabrice Quet; Michel Cogne; Jean-Paul Fermand
High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis.
The New England journal of medicine 2007;357(11):1083-93.
2007: Philippe Moreau; Michel Attal; Frédéric Garban; Cyrille Hulin; Thierry Facon; Gérald Marit; Mauricette Michallet; Chantal Doyen; S Leyvraz; Mohamad Mohty; Marc Wetterwald; Claire Mathiot; Denis Caillot; Christian Berthou; Lotfi Benboubker; Laurent Garderet; Carine Chaleteix; Catherine Traullé; Jean-Gabriel Fuzibet; Jérôme Jaubert; Thierry Lamy; Philippe Casassus; M Dib; B Kolb; Véronique Dorvaux; Bernard Grosbois; Ibrahim Yakoub-Agha; Jean-Luc Harousseau; Hervé Avet-Loiseau
Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials.
Leukemia 2007;21(9):2020-4.
2007: Françoise Mégret; Christophe Prehaud; Mireille Lafage; Philippe Moreau; Nathalie Rouas-Freiss; Edgardo D Carosella; Monique Lafon
Modulation of HLA-G and HLA-E expression in human neuronal cells after rabies virus or herpes virus simplex type 1 infections.
Human immunology 2007;68(4):294-302.
2007: Gaël Mouillot; Céline Marcou; Inès Zidi; Chrsitine Guillard; Déborah Sangrouber; Edgardo D Carosella; Philippe Moreau
Hypoxia modulates HLA-G gene expression in tumor cells.
Human immunology 2007;68(4):277-85.
2007: Philippe Moreau; Laurent Voillat; L Benboukher; Claire Mathiot; Charles Dumontet; Nelly Robillard; O Hérault; Francine Garnache; Richard Garand; N Varoqueaux; Hervé Avet-Loiseau; Jean-Luc Harousseau; R Bataille
Rituximab in CD20 positive multiple myeloma.
Leukemia 2007;21(4):835-6.
2007: Julien Caumartin; Benoit Favier; Marina Daouya; Chrsitine Guillard; Philippe Moreau; Edgardo D Carosella; Joël LeMaoult
Trogocytosis-based generation of suppressive NK cells.
The EMBO journal 2007;26(5):1423-33.
2007: Benoit Favier; Joël LeMaoult; Nathalie Rouas-Freiss; Philippe Moreau; Catherine Menier; Edgardo D Carosella
Research on HLA-G: an update.
Tissue antigens 2007;69(3):207-11.
2007: Cyrille Touzeau; Catherine Pellat-Deceunynck; Thomas Gastinne; F Accard; G Jego; Hervé Avet-Loiseau; Nelly Robillard; Jean-Luc Harousseau; Régis Bataille; Philippe Moreau
Reactive plasmacytoses can mimick plasma cell leukemia: therapeutical implications.
Leukemia & lymphoma 2007;48(1):207-8.
2006: Michel Attal; Jean-Luc Harousseau; Serge Leyvraz; Chantal Doyen; Cyrille Hulin; Lotfi Benboubker; Ibrahim Yakoub-Agha; Jean-Henri Bourhis; Laurent Garderet; Brigitte Pegourie; Charles Dumontet; Marc Renaud; Laurent Voillat; Christian Berthou; Gérald Marit; Mathieu Monconduit; Denis Caillot; Bernard Grobois; Hervé Avet-Loiseau; Philippe Moreau; Thierry Facon
Maintenance therapy with thalidomide improves survival in patients with multiple myeloma.
Blood 2006;108(10):3289-94.
2006: Inès Zidi; Chrsitine Guillard; Céline Marcou; Irène Krawice-Radanne; Déborah Sangrouber; Nathalie Rouas-Freiss; Edgardo D Carosella; Philippe Moreau
Increase in HLA-G1 proteolytic shedding by tumor cells: a regulatory pathway controlled by NF-kappaB inducers.
Cellular and molecular life sciences : CMLS 2006;63(22):2669-81.
2006: Jean-Luc Harousseau; Michel Attal; Xavier Leleu; Jacques Troncy; Brigitte Pegourie; Anne-Marie Stoppa; Cyrille Hulin; Lotfi Benboubker; Jean-Gabriel Fuzibet; Marc Renaud; Philippe Moreau; Hervé Avet-Loiseau
Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of an IFM phase II study.
Haematologica 2006;91(11):1498-505.
2006: Emmanuelle Menoret; Patricia Gomez-Bougie; Alexandrine Geffroy-Luseau; Sylvanne Daniels; Philippe Moreau; Steven Le Gouill; Jean-Luc Harousseau; Régis Bataille; Martine Amiot; Catherine Pellat-Deceunynck
Mcl-1L cleavage is involved in TRAIL-R1- and TRAIL-R2-mediated apoptosis induced by HGS-ETR1 and HGS-ETR2 human mAbs in myeloma cells.
Blood 2006;108(4):1346-52.
2006: Stéphane Vigouroux; Odile Morin; Philippe Moreau; Jean-Luc Harousseau; Noël Milpied
Candidemia in patients with hematologic malignancies: analysis of 7 years' experience in a single center.
Haematologica 2006;91(5):717-8.
2006: Frédéric Garban; Michel Attal; Mauricette Michallet; Cyrille Hulin; Jean-Henri Bourhis; Ibrahim Yakoub-Agha; Thierry Lamy; Gérald Marit; Frédéric Maloisel; Christian Berthou; Mamoun Dib; Denis Caillot; Bernard Deprijck; Nicolas Ketterer; Jean-Luc Harousseau; Jean-Jacques Sotto; Philippe Moreau
Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma.
Blood 2006;107(9):3474-80.
2006: Philippe Moreau; Nelly Robillard; Gaétan Jégo; Catherine Pellat; Steven Le Gouill; Soraya Thoumi; Hervé Avet-Loiseau; Jean-Luc Harousseau; Régis Bataille
Lack of CD27 in myeloma delineates different presentation and outcome.
British journal of haematology 2006;132(2):168-70.
2006: Philippe Moreau; Cyrille Hullin; Frédéric Garban; Ibrahim Yakoub-Agha; Lotfi Benboubker; Michel Attal; Gérald Marit; Jean-Gabriel Fuzibet; Chantal Doyen; Laurent Voillat; Christian Berthou; Nicolas Ketterer; Philippe Casassus; Mathieu Monconduit; Mauricette Michallet; Albert Najman; Jean-Jacques Sotto; Régis Bataille; Jean-Luc Harousseau
Tandem autologous stem cell transplantation in high-risk de novo multiple myeloma: final results of the prospective and randomized IFM 99-04 protocol.
Blood 2006;107(1):397-403.
2005: Monique Lafon; Christophe Prehaud; Françoise Megret; Mireille Lafage; Gaël Mouillot; Michèle Roa; Philippe Moreau; Nathalie Rouas-Freiss; Edgardo D Carosella
Modulation of HLA-G expression in human neural cells after neurotropic viral infections.
Journal of virology 2005;79(24):15226-37.
2005: Nathalie Rouas-Freiss; Philippe Moreau; Soldano Ferrone; Edgardo D Carosella
HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?
Cancer research 2005;65(22):10139-44.
2005: Nathalie Rouas-Freiss; Sylvie Bruel; Catherine Menier; Céline Marcou; Philippe Moreau; Edgardo D Carosella
Switch of HLA-G alternative splicing in a melanoma cell line causes loss of HLA-G1 expression and sensitivity to NK lysis.
International journal of cancer. Journal international du cancer 2005;117(1):114-22.
2005: Jean-Luc Harousseau; Philippe Moreau
Evolving role of stem cell transplantation in multiple myeloma.
Clinical lymphoma & myeloma 2005;6(2):89-95.
2005: Patrice Chevallier; Virginie Roland; Béatrice Mahé; Nadine Juge-Morineau; Viviane Dubruille; Thierry Guillaume; Stéphane Vigouroux; Philippe Moreau; Noël Milpied; Richard Garand; Hervé Avet-Loiseau; Jean-Luc Harousseau
Administration of mylotarg 4 days after beginning of a chemotherapy including intermediate-dose aracytin and mitoxantrone (MIDAM regimen) produces a high rate of complete hematologic remission in patients with CD33+ primary resistant or relapsed acute myeloid leukemia.
Leukemia research 2005;29(9):1003-7.
2005: Alvaro González-Hernandez; Joël LeMaoult; Ana Lopez; Estibaliz Alegre; Julien Caumartin; Solène Le Rond; Marina Daouya; Philippe Moreau; Edgardo D Carosella
Linking two immuno-suppressive molecules: indoleamine 2,3 dioxygenase can modify HLA-G cell-surface expression.
Biology of reproduction 2005;73(3):571-8.
2005: Magali Le Discorde; Caroline Le Danff; Philippe Moreau; Nathalie Rouas-Freiss; Edgardo D Carosella
HLA-G*0105N null allele encodes functional HLA-G isoforms.
Biology of reproduction 2005;73(2):280-8.
2005: Soraya Wuillème-Toumi; Nelly Robillard; P Gomez; Philippe Moreau; Steven Le Gouill; Hervé Avet-Loiseau; Jean-Luc Harousseau; Martine Amiot; Régis Bataille
Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival.
Leukemia 2005;19(7):1248-52.
2005: Gaël Mouillot; Céline Marcou; Philippe Rousseau; Nathalie Rouas-Freiss; Edgardo D Carosella; Philippe Moreau
HLA-G gene activation in tumor cells involves cis-acting epigenetic changes.
International journal of cancer. Journal international du cancer 2005;113(6):928-36.
2005: Stéphane Vigouroux; Odile Morin; Philippe Moreau; Françoise Méchinaud; Nadine Morineau; Béatrice Mahé; Patrice Chevallier; Thierry Guillaume; Viviane Dubruille; Jean-Luc Harousseau; Noël Milpied
Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(4):e35-7.
2004: Nicolas Blin; Nadine Morineau; Fanny Gaillard; Odile Morin; Noël Milpied; Jean-Luc Harousseau; Philippe Moreau
Disseminated mucormycosis associated with invasive pulmonary aspergillosis in a patient treated for post-transplant high-grade non-Hodgkin's lymphoma.
Leukemia & lymphoma 2004;45(10):2161-3.
2004: Philippe Moreau; Nelly Robillard; Hervé Avet-Loiseau; Danielle Pineau; Nadine Morineau; Noël Milpied; Jean-Luc Harousseau; Régis Bataille
Patients with CD45 negative multiple myeloma receiving high-dose therapy have a shorter survival than those with CD45 positive multiple myeloma.
Haematologica 2004;89(5):547-51.
2004: Joël Le Maoult; Nathalie Rouas-Freiss; Magali Le Discorde; Philippe Moreau; Edgardo D Carosella
[HLA-G in organ transplantation].
Pathologie-biologie 2004;52(2):97-103.
2004: Philippe Rousseau; krzysztof masternak; Michal Krawczyk; Walter Reith; Jean Dausset; Edgardo D Carosella; Philippe Moreau
In vivo, RFX5 binds differently to the human leucocyte antigen-E, -F, and -G gene promoters and participates in HLA class I protein expression in a cell type-dependent manner.
Immunology 2004;111(1):53-65.
2003: Magali Le Discorde; Philippe Moreau; Patrick Sabatier; Jean-Marc Legeais; Edgardo D Carosella
Expression of HLA-G in human cornea, an immune-privileged tissue.
Human immunology 2003;64(11):1039-44.
2003: Philippe Rousseau; Magali Le Discorde; Gaël Mouillot; Céline Marcou; Edgardo D Carosella; Philippe Moreau
The 14 bp deletion-insertion polymorphism in the 3' UT region of the HLA-G gene influences HLA-G mRNA stability.
Human immunology 2003;64(11):1005-10.
2003: Nathalie Rouas-Freiss; Philippe Moreau; Catherine Menier; Edgardo D Carosella
HLA-G in cancer: a way to turn off the immune system.
Seminars in cancer biology 2003;13(5):325-36.
2003: Richard Garand; Hervé Avet-Loiseau; F Accard; Philippe Moreau; Jean-Luc Harousseau; Régis Bataille
t(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma.
Leukemia 2003;17(10):2032-5.
2003: Joël LeMaoult; Magali Le Discorde; Nathalie Rouas-Freiss; Philippe Moreau; Catherine Menier; J McCluskey; Edgardo D Carosella
Biology and functions of human leukocyte antigen-G in health and sickness.
Tissue antigens 2003;62(4):273-84.
2003: Eric Solary; Bernard Drenou; Lydia Campos; Patricia de Crémoux; Francine Mugneret; Philippe Moreau; Bruno Lioure; Annie Falkenrodt; Brigitte Witz; Marc Bernard; Mathilde Hunault-Berger; Martine Delain; José Fernandes; Christiane Mounier; françois guilhot; Francine Garnache; Christian Berthou; Fawzi Kara-Slimane; Jean-Luc Harousseau
Quinine as a multidrug resistance inhibitor: a phase 3 multicentric randomized study in adult de novo acute myelogenous leukemia.
Blood 2003;102(4):1202-10.
2003: Nelly Robillard; Hervé Avet-Loiseau; Richard Garand; Philippe Moreau; Danielle Pineau; Marie-Josée Rapp; Jean-Luc Harousseau; Régis Bataille
CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma.
Blood 2003;102(3):1070-1.
2003: Béatrice Mahé; Noël Milpied; Marie-Paule Mellerin; Philippe Moreau; Nadine Morineau; Magda Vigier; Jean-Luc Harousseau
PCR detection of residual Bcl-2/IgH-positive cells after high-dose therapy with autologous stem cell transplantation is a prognostic factor for event-free survival in patients with low-grade follicular non-Hodgkin's lymphoma.
Bone marrow transplantation 2003;31(6):467-73.
2003: Philippe Moreau; Gaël Mouillot; Philippe Rousseau; Céline Marcou; Jean Dausset; Edgardo D Carosella
HLA-G gene repression is reversed by demethylation.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(3):1191-6.
2003: Edgardo D Carosella; Philippe Moreau; Joël Le Maoult; Magali Le Discorde; Jean Dausset; Nathalie Rouas-Freiss
HLA-G molecules: from maternal-fetal tolerance to tissue acceptance.
Advances in immunology 2003;81():199-252.
2003: Nathalie Rouas-Freiss; Joël LeMaoult; Philippe Moreau; Jean Dausset; Edgardo D Carosella
HLA-G in transplantation: a relevant molecule for inhibition of graft rejection?
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2003;3(1):11-6.
2002: Philippe Moreau; Jean Dausset; Edgardo D Carosella; Nathalie Rouas-Freiss
Viewpoint on the functionality of the human leukocyte antigen-G null allele at the fetal-maternal interface.
Biology of reproduction 2002;67(5):1375-8.
2002: Philippe Moreau; Philippe Rousseau; Nathalie Rouas-Freiss; Magali Le Discorde; Jean Dausset; Edgardo D Carosella
HLA-G protein processing and transport to the cell surface.
Cellular and molecular life sciences : CMLS 2002;59(9):1460-6.
2002: Philippe Moreau; R Misbahi; Noël Milpied; Nadine Morineau; Béatrice Mahé; Magda Vigier; Marie-Josée Rapp; Régis Bataille; Jean-Luc Harousseau
Long-term results (12 years) of high-dose therapy in 127 patients with de novo multiple myeloma.
Leukemia 2002;16(9):1838-43.
2002: Philippe Moreau; Thierry Facon; Xavier Leleu; Nadine Morineau; Pauline Huyghe; Jean-Luc Harousseau; Régis Bataille; Hervé Avet-Loiseau
Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy.
Blood 2002;100(5):1579-83.
2002: Stéphane Vigouroux; Noël Milpied; J M Andrieu; P Colonna; Norbert Ifrah; Philippe Colombat; Bernard Desablens; Jean-François Abgrall; Philippe Casassus; françois guilhot; Josette Briere; Annick Le Mevel; Philippe Moreau; F Mechinaud; Béatrice Mahe; Nadine Morineau; Magda Vigier; Marie-Josée Rapp; Jean-Luc Harousseau
Front-line high-dose therapy with autologous stem cell transplantation for high risk Hodgkin's disease: comparison with combined-modality therapy.
Bone marrow transplantation 2002;29(10):833-42.
2002: Magali Le Discorde; Philippe Moreau; Nathalie Rouas-Freiss; Edgardo D Carosella
[HLA-G: immune tolerance in normal and pathological physiology].
Pathologie-biologie 2002;50(1):45-51.
2002: Philippe Moreau; Thierry Facon; Michel Attal; Cyrille Hulin; Mauricette Michallet; Frédéric Maloisel; Jean-Jacques Sotto; françois guilhot; Gérald Marit; Chantal Doyen; Jérôme Jaubert; Jean-Gabriel Fuzibet; Sylvie François; Lotfi Benboubker; Mathieu Monconduit; Laurent Voillat; Margaret Macro; Christian Berthou; Véronique Dorvaux; Bernard Pignon; Bernard Rio; Thomas Matthes; Philippe Casassus; Denis Caillot; Norbert Najman; Bernard Grosbois; Régis Bataille; Jean-Luc Harousseau
Comparison of 200 mg/m(2) melphalan and 8 Gy total body irradiation plus 140 mg/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myélome 9502 randomized trial.
Blood 2002;99(3):731-5.
2002: Ibrahim Yakoub-Agha; Michel Attal; Charles Dumontet; Valérie Delannoy; Philippe Moreau; Christian Berthou; Thierry Lamy; Bernard Grosbois; Charly Dauriac; Véronique Dorvaux; Jacques-Olivier Bay; Mathieu Monconduit; Jean-Luc Harousseau; Corinne Duguet; Alain Duhamel; Thierry Facon
Thalidomide in patients with advanced multiple myeloma: a study of 83 patients--report of the Intergroupe Francophone du Myélome (IFM).
The hematology journal : the official journal of the European Haematology Association / EHA 2002;3(4):185-92.
2002: Patrice Chevallier; Dominique Penther; Hervé Avet-Loiseau; Nelly Robillard; Norbert Ifrah; Béatrice Mahé; Mohamed Hamidou; Hervé Maisonneuve; Philippe Moreau; Henri Jardel; Jean-Luc Harousseau; Régis Bataille; Richard Garand
CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia.
British journal of haematology 2002;116(1):142-50.
2001: M O'Brien; T McCarthy; D Jenkins; P Paul; Jean Dausset; Edgardo D Carosella; Philippe Moreau
Altered HLA-G transcription in pre-eclampsia is associated with allele specific inheritance: possible role of the HLA-G gene in susceptibility to the disease.
Cellular and molecular life sciences : CMLS 2001;58(12-13):1943-9.
2001: Mauricette Michallet; Karin Bilger; Frédéric Garban; Michel Attal; A Huyn; Didier Blaise; Noël Milpied; Philippe Moreau; Pierre Bordigoni; Mathieu Kuentz; Alain Sadoun; Jean-Yves Cahn; Gérard Socié; Xavier Thomas; P Arnaud; N Raus; Véronique Lhéritier; Arnaud Pigneux; Jean-Michel Boiron
Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(14):3340-9.
2001: E Ninin; Noël Milpied; Philippe Moreau; B André-Richet; Nadine Morineau; Béatrice Mahé; Magda Vigier; B M Imbert; Odile Morin; Jean-Luc Harousseau; Hervé Richet
Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;33(1):41-7.
2001: Béatrice Riteau; Philippe Moreau; Catherine Menier; I Khalil-Daher; Kiarash Khosrotehrani; R Bras-Goncalves; P Paul; Jean Dausset; Nathalie Rouas-Freiss; Edgardo D Carosella
Characterization of HLA-G1, -G2, -G3, and -G4 isoforms transfected in a human melanoma cell line.
Transplantation proceedings 2001;33(3):2360-4.
2001: Philippe Moreau; O Faure; S Lefebvre; El Chérif Ibrahim; M O'Brien; L Gourand; Jean Dausset; Edgardo D Carosella; P Paul
Glucocorticoid hormones upregulate levels of HLA-G transcripts in trophoblasts.
Transplantation proceedings 2001;33(3):2277-80.
2001: S Lefebvre; Sonia Berrih-Aknin; F Adrian; Philippe Moreau; S Poea; L Gourand; Jean Dausset; Edgardo D Carosella; P Paul
A specific interferon (IFN)-stimulated response element of the distal HLA-G promoter binds IFN-regulatory factor 1 and mediates enhancement of this nonclassical class I gene by IFN-beta.
The Journal of biological chemistry 2001;276(9):6133-9.
2001: O Thomas; Marc-André Mahé; Loïc Campion; S Bourdin; Noël Milpied; G Brunet; Albert Lisbona; Annick Le Mevel; Philippe Moreau; Jean-Luc Harousseau; JC Cuillière
Long-term complications of total body irradiation in adults.
International journal of radiation oncology, biology, physics 2001;49(1):125-31.
2000: Edgardo D Carosella; P Paul; Philippe Moreau; Nathalie Rouas-Freiss
HLA-G and HLA-E: fundamental and pathophysiological aspects.
Immunology today 2000;21(11):532-4.
2000: P Paul; Nathalie Rouas-Freiss; Philippe Moreau; FA Cabestre; Catherine Menier; I Khalil-Daher; Céline Pangault; M Onno; Renée Fauchet; J Martinez-Laso; P Morales; A A Villena; Patrizio Giacomini; Pier Giorgio Natali; Guido Frumento; Giovanni Battista Ferrara; M McMaster; S Fisher; D Schust; S Ferrone; Jean Dausset; D Geraghty; Edgardo D Carosella
HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression.
Human immunology 2000;61(11):1177-95.
2000: Philippe Rousseau; P Paul; M O'Brien; Jean Dausset; Edgardo D Carosella; Philippe Moreau
The X1 box of HLA-G promoter is a target site for RFX and Sp1 factors.
Human immunology 2000;61(11):1132-7.
2000: M O'Brien; Jean Dausset; Edgardo D Carosella; Philippe Moreau
Analysis of the role of HLA-G in preeclampsia.
Human immunology 2000;61(11):1126-31.
2000: S Lefebvre; F Adrian; Philippe Moreau; L Gourand; Jean Dausset; Sonia Berrih-Aknin; Edgardo D Carosella; P Paul
Modulation of HLA-G expression in human thymic and amniotic epithelial cells.
Human immunology 2000;61(11):1095-101.
2000: Nadine Morineau; X W Tang; Philippe Moreau; Noël Milpied; Béatrice Mahé; Régis Bataille; Jean-Luc Harousseau
Lack of benefit of CD34+ cell selected over non-selected peripheral blood stem cell transplantation in multiple myeloma: results of a single center study.
Leukemia 2000;14(10):1815-20.
2000: G Jego; Hervé Avet-Loiseau; Nelly Robillard; Philippe Moreau; Martine Amiot; Jean-Luc Harousseau; Catherine Pellat-Deceunynck; Régis Bataille
Reactive plasmacytoses in multiple myeloma during hematopoietic recovery with G- or GM-CSF.
Leukemia research 2000;24(7):627-30.
2000: Marc-André Mahé; S Bourdin; A Le Pourhiet-Le Mevel; Philippe Moreau; Loïc Campion; Mohamed Hamidou; Noël Milpied; Anne Moreau; Fanny Gaillard; Jean-Luc Harousseau; JC Cuillière
Salvage extended-field irradiation in follicular non-Hodgkin's lymphoma after failure of chemotherapy.
International journal of radiation oncology, biology, physics 2000;47(3):735-8.
2000: Steven Le Gouill; Pascaline Talmant; Noël Milpied; A Daviet; M Ancelot; Philippe Moreau; Jean-Luc Harousseau; Régis Bataille; Hervé Avet-Loiseau
Fluorescence in situ hybridization on peripheral-blood specimens is a reliable method to evaluate cytogenetic response in chronic myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(7):1533-8.
2000: Ibrahim Yakoub-Agha; Philippe Moreau; S Leyvraz; Christian Berthou; C Payen; Charles Dumontet; Bernard Grosbois; P Beris; Corinne Duguet; Michel Attal; Jean-Luc Harousseau; Thierry Facon
Thalidomide in patients with advanced multiple myeloma.
The hematology journal : the official journal of the European Haematology Association / EHA 2000;1(3):186-9.
1999: D Puthier; Sophie Derenne; S Barillé; Philippe Moreau; Jean-Luc Harousseau; Régis Bataille; Martine Amiot
Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells.
British journal of haematology 1999;107(2):392-5.
1999: S Barillé; W Thabard; Nelly Robillard; Philippe Moreau; Danielle Pineau; Jean-Luc Harousseau; Régis Bataille; Martine Amiot
CD130 rather than CD126 expression is associated with disease activity in multiple myeloma.
British journal of haematology 1999;106(2):532-5.
1999: S Lefebvre; Philippe Moreau; V Guiard; El Chérif Ibrahim; F Adrian-Cabestre; Catherine Menier; Jean Dausset; Edgardo D Carosella; P Paul
Molecular mechanisms controlling constitutive and IFN-gamma-inducible HLA-G expression in various cell types.
Journal of reproductive immunology 1999;43(2):213-24.
1999: F Adrián Cabestré; Philippe Moreau; Béatrice Riteau; El Chérif Ibrahim; Caroline Le Danff; Jean Dausset; Nathalie Rouas-Freiss; Edgardo D Carosella; P Paul
HLA-G expression in human melanoma cells: protection from NK cytolysis.
Journal of reproductive immunology 1999;43(2):183-93.
1999: Philippe Moreau; Noël Milpied; Béatrice Mahé; Nadine Juge-Morineau; Marie-Josée Rapp; Régis Bataille; Jean-Luc Harousseau
Melphalan 220 mg/m2 followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myeloma.
Bone marrow transplantation 1999;23(10):1003-6.
1999: Philippe Moreau; F Adrian-Cabestre; Catherine Menier; V Guiard; L Gourand; Jean Dausset; Edgardo D Carosella; P Paul
IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes.
International immunology 1999;11(5):803-11.
1999: S Lefebvre; Philippe Moreau; Jean Dausset; Edgardo D Carosella; P Paul
Downregulation of HLA class I gene transcription in choriocarcinoma cells is controlled by the proximal promoter element and can be reversed by CIITA.
Placenta 1999;20(4):293-301.
1999: Noël Milpied; M Coste-Burel; F Accard; A Moreau; Philippe Moreau; Richard Garand; Jean-Luc Harousseau
Epstein-Barr virus-associated B cell lymphoproliferative disease after non-myeloablative allogeneic stem cell transplantation.
Bone marrow transplantation 1999;23(6):629-30.
1999: Philippe Moreau; A Huynh; Thierry Facon; I Bouilly; J J Sotto; Laurence Legros; Noël Milpied; Michel Attal; R Bataille; Jean-Luc Harousseau
Lack of efficacy of clarithromycin in advanced multiple myeloma. Intergroupe Français du Myélome (IFM)
Leukemia 1999;13(3):490-1.
1999: FA Cabestre; S Lefebvre; Philippe Moreau; N Rouas-Friess; Jean Dausset; Edgardo D Carosella; P Paul
HLA-G expression: immune privilege for tumour cells?
Seminars in cancer biology 1999;9(1):27-36.
1998: Philippe Moreau; S Lefebvre; L Gourand; Jean Dausset; Edgardo D Carosella; P Paul
Specific binding of nuclear factors to the HLA-G gene promoter correlates with a lack of HLA-G transcripts in first trimester human fetal liver.
Human immunology 1998;59(12):751-7.
1998: Noël Milpied; Fanny Gaillard; Philippe Moreau; Béatrice Mahé; J Souchet; Marie-Josée Rapp; Claude-Eric Bulabois; Nadine Morineau; Jean-Luc Harousseau
High-dose therapy with stem cell transplantation for mantle cell lymphoma: results and prognostic factors, a single center experience.
Bone marrow transplantation 1998;22(7):645-50.
1998: Philippe Moreau; P Paul; Nathalie Rouas-Freiss; Marek Kirszenbaum; Jean Dausset; Edgardo D Carosella
Molecular and immunologic aspects of the nonclassical HLA class I antigen HLA-G: evidence for an important role in the maternal tolerance of the fetal allograft.
American journal of reproductive immunology (New York, N.Y. : 1989) 1998;40(3):136-44.
1998: Philippe Moreau; Noël Milpied; Marie-Josée Rapp; Anne Moreau; S Bourdin; M A Mahe; B Dupas; S Le Tortorec; Mohamed Hamidou; H Maisoneuve; Béatrice Mahe; Claude-Eric Bulabois; Nadine Morineau; Henri Jardel; Jean-Luc Harousseau
Early intensive therapy with autologous stem cell transplantation in high-risk Hodgkin's disease: long-term follow-up in 35 cases.
Leukemia & lymphoma 1998;30(3-4):313-24.
1998: Philippe Moreau; Noël Milpied; Laurent Voillat; Philippe Colombat; Béatrice Mahé; Marie-Josée Rapp; Anne Moreau; B Dupas; Claude-Eric Bulabois; Nadine Juge-Morineau; Jean-Luc Harousseau
Peripheral blood stem cell transplantation as front-line therapy in patients aged 61 to 65 years: a pilot study.
Bone marrow transplantation 1998;21(12):1193-6.
1998: Philippe Moreau; V Leblond; P Bourquelot; Thierry Facon; A Huynh; Denis Caillot; O Hermine; Michel Attal; M Hamidou; G Nedellec; A Ferrant; Bruno Audhuy; R Bataille; Noël Milpied; Jean-Luc Harousseau
Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients.
British journal of haematology 1998;101(4):766-9.
1998: P Paul; Nathalie Rouas-Freiss; I Khalil-Daher; Philippe Moreau; Béatrice Riteau; Frédérique-Anne Le Gal; M F Avril; Jean Dausset; Jean-Gérard Guillet; Edgardo D Carosella
HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(8):4510-5.
1998: Philippe Moreau; Joel Fleury; Pauline Brice; Philippe Colombat; Reda Bouabdallah; Bruno Lioure; Laurent Voillat; Olivier Casasnovas; Sylvie François; Alain Sadoun; Thierry Lamy; Jean-Pierre Lotz; Jean-Nicolas Munck; Marine Divine; Christophe Fermé; A M Pény; Christophe Fruchart; P Oriol; M Ojeda; Oumedaly Reman; Noël Milpied; Christian Gisselbrecht; Michel Legros; Jean-Luc Harousseau
Early intensive therapy with autologous stem cell transplantation in advanced Hodgkin's disease: retrospective analysis of 158 cases from the French registry.
Bone marrow transplantation 1998;21(8):787-93.
1998: Marc-André Mahé; S Bourdin; Annick Le Mevel; Philippe Moreau; Anne Moreau; Mohamed Hamidou; Fanny Gaillard; Marie-Josée Rapp; Noël Milpied; Jean-Luc Harousseau
Long-term results of total abdominopelvic irradiation in non-Hodgkin's lymphomas after failure of chemotherapy.
International journal of radiation oncology, biology, physics 1998;41(1):117-21.
1997: Pauline Brice; Reda Bouabdallah; Philippe Moreau; Marine Divine; M André; M Aoudjane; Joel Fleury; B Anglaret; André Baruchel; L Sensebe; Philippe Colombat
Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de Moëlle.
Bone marrow transplantation 1997;20(1):21-6.
1997: Pauline Brice; Y Bastion; Eric Lepage; Nicole Brousse; C Haïoun; Philippe Moreau; N Straetmans; Hervé Tilly; I Tabah; Philippe Solal-Céligny
Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(3):1110-7.
1997: Philippe Moreau; Denis Fiere; W R Bezwoda; Thierry Facon; Michel Attal; J P Laporte; P Colombat; H L Haak; Mathieu Monconduit; H Lockhorst; D Girault; Jean-Luc Harousseau
Prospective randomized placebo-controlled study of granulocyte-macrophage colony-stimulating factor without stem-cell transplantation after high-dose melphalan in patients with multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):660-6.
1997: Philippe Moreau; P Paul; L Gourand; Stéphane Prost; Jean Dausset; Edgardo D Carosella; Marek Kirszenbaum
HLA-G gene transcriptional regulation in trophoblasts and blood cells: differential binding of nuclear factors to a regulatory element located 1.1 kb from exon 1.
Human immunology 1997;52(1):41-6.
1996: Philippe Moreau; Marie-France Kergueris; Noël Milpied; S Le Tortorec; Béatrice Mahé; Claude-Eric Bulabois; Marie-Josée Rapp; C Larousse; Régis Bataille; Jean-Luc Harousseau
A pilot study of 220 mg/m2 melphalan followed by autologous stem cell transplantation in patients with advanced haematological malignancies: pharmacokinetics and toxicity.
British journal of haematology 1996;95(3):527-30.
1996: Philippe Moreau; F Méchinaud; Béatrice Mahé; S Le Tortorec; Marie-Josée Rapp; H Maisonneuve; Jean-Luc Harousseau; Noël Milpied
Successful allogeneic bone marrow transplantation for early relapse after autologous bone marrow transplantation in two cases of aggressive high-grade non-Hodgkin's lymphoma.
Bone marrow transplantation 1996;18(3):665-7.
1996: Eric Solary; B Witz; Denis Caillot; Philippe Moreau; Bernard Desablens; Jean-Yves Cahn; Alain Sadoun; Bernard Pignon; Christian Berthou; Frédéric Maloisel; Denis Guyotat; Philippe Casassus; Norbert Ifrah; Y Lamy; Bruno Audhuy; Philippe Colombat; Jean-Luc Harousseau
Combination of quinine as a potential reversing agent with mitoxantrone and cytarabine for the treatment of acute leukemias: a randomized multicenter study.
Blood 1996;88(4):1198-205.
1996: Béatrice Mahé; Noël Milpied; Sylvie Hermouet; Nelly Robillard; Philippe Moreau; S Letortorec; Marie-Josée Rapp; Régis Bataille; Jean-Luc Harousseau
G-CSF alone mobilizes sufficient peripheral blood CD34+ cells for positive selection in newly diagnosed patients with myeloma.
British journal of haematology 1996;92(2):263-8.
1995: Béatrice Mahé; F Gaillard; F Labadie; S Papin; S Letortorec; Philippe Moreau; Jean-Luc Harousseau; Noël Milpied
Occurrence of a T cell lymphoma in a patient with chronic myeloid leukemia treated with alpha interferon.
Leukemia & lymphoma 1995;19(5-6):515-7.
1995: M Teyssier; Armand Bensussan; Marek Kirszenbaum; Philippe Moreau; Eliane Gluckman; Jean Dausset; Edgardo D Carosella
Natural killer cells are the unique lymphocyte cell subset which do not express HLA-G.
Natural immunity 1995;14(5-6):262-70.
1995: Philippe Moreau; Edgardo D Carosella; Eliane Gluckman; L Gourand; Stéphane Prost; Jean Dausset; Marek Kirszenbaum
[Alternative transcripts of the MHC of the non-classical class I HLA-G gene in the in trophoblast during the first pregnancy trimester and in the placenta at term].
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1995;318(8):837-42.
1995: Marek Kirszenbaum; Philippe Moreau; M Teyssier; C Lafon; Eliane Gluckman; Jean Dausset; Edgardo D Carosella
Evidence for the presence of the alternatively spliced HLA-G mRNA forms in human mononuclear cells from peripheral blood and umbilical cord blood.
Human immunology 1995;43(3):237-41.
1995: Philippe Moreau; Edgardo D Carosella; M Teyssier; Stéphane Prost; Eliane Gluckman; Jean Dausset; Marek Kirszenbaum
Soluble HLA-G molecule. An alternatively spliced HLA-G mRNA form candidate to encode it in peripheral blood mononuclear cells and human trophoblasts.
Human immunology 1995;43(3):231-6.
1995: Béatrice Mahé; Anne Moreau; Philippe Moreau; S Le Tortorec; Jean-Luc Harousseau; Noël Milpied
High dose radiochemotherapy followed by autologous stem cell transplantation in four patients with multiple lymphomatous polyposis.
Cancer 1995;75(11):2742-6.
1994: Philippe Moreau; S Le Tortorec; Béatrice Mahé; L Legros; Noël Milpied; Jean-Luc Harousseau
Administration of granulocyte colony-stimulating factor from day 7 after autologous bone marrow transplantation: effects on neutropenia and duration of hospitalization.
Nouvelle revue française d'hématologie 1994;36(6):455-8.
1994: Philippe Moreau; S LeTortorec; Marc-André Mahé; Béatrice Mahé; Anne Moreau; S Bourdin; Claude-Eric Bulabois; B Bureau; Jean-Luc Harousseau; Noël Milpied
Autologous bone marrow transplantation using TBI and CBV for disseminated high/intermediate grade cutaneous non-epidermotropic non-Hodgkin's lymphoma.
Bone marrow transplantation 1994;14(5):775-8.
1994: D P Wu; Noël Milpied; Philippe Moreau; F Mechinaud-Lacroix; B Mahe; S Le Tortorec; Marie-Josée Rapp; S Bourdin; J M Mahe; Jean-Luc Harousseau
Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
Bone marrow transplantation 1994;14(5):751-7.
1994: Béatrice Mahé; Philippe Moreau; B Bonnemain; S Letortorec; D Menegali; S Bourdin; D De Lajartre; Jean-Luc Harousseau
Isolated Richter's syndrome of the brain: two recent cases.
Nouvelle revue française d'hématologie 1994;36(5):383-5.
1994: B Mahe; Philippe Moreau; S Le Tortorec; M Hourmant; Jean-Luc Harousseau; Noël Milpied
Autologous bone marrow transplantation for cyclosporin-related lymphoma in a renal transplant patient.
Bone marrow transplantation 1994;14(4):645-6.
1994: Marek Kirszenbaum; Philippe Moreau; Eliane Gluckman; Jean Dausset; Edgardo D Carosella
An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(10):4209-13.
1994: Philippe Moreau; M Teyssier; Marek Kirszenbaum; Eliane Gluckman; L Gourand; Edgardo D Carosella; Jean Dausset
HLA-G mRNA forms in human trophoblasts and peripheral blood lymphocytes: potential use in prenatal diagnosis.
Folia biologica 1994;40(6):431-8.
1993: Philippe Moreau; Noël Milpied; F Mechinaud-Lacroix; B Mahe; Marie-Josée Rapp; S Le Tortorec; S Bourdin; B Dupas; Jean-Luc Harousseau
Early intensive therapy with autotransplantation for high-risk Hodgkin's disease.
Leukemia & lymphoma 1993;12(1-2):51-8.
1991: Philippe Moreau; Pascaline Talmant; Noël Milpied; Richard Garand; G Lefranc; Jean-Luc Harousseau
Trisomy 4 associated with acute lymphocytic leukaemia.
British journal of haematology 1991;78(4):576.